Pharma Pulse 8/12/24: Getting Unstuck in Digital Transformation, ePharmacies Strategic Business Report 2024 & more

Getting Unstuck on the Path to Digital Transformation

The transition to AI and machine learning was well underway long before ChatGPT burst onto the marketplace; however, organizations were, and still are, constrained by data challenges.

FDA Approves First Nasal Spray for Anaphylaxis

The FDA approved neffy (ARS Pharmaceuticals), an epinephrine nasal spray for the emergency treatment of allergic reactions, including anaphylaxis, for adults and pediatric individuals who weigh at least 30 kg. This marks the first approval for a nasal spray for the treatment of anaphylaxis, according to the agency.

Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion

Merck will acquire full global rights to clinical-stage bispecific antibody CN201 from Curon Biopharmaceutical.

ePharmacies Strategic Business Report 2024: Market to Reach $323.8 Billion by 2030 - Expansion into Rural and Remote Areas Expands Opportunities

The "ePharmacies - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for ePharmacies is estimated at US$97.9 Billion in 2023 and is projected to reach US$323.8 Billion by 2030, growing at a CAGR of 18.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Fleming CFO, Inc. on LinkedIn

So you've achieved that long sought-after financial milestone. Congrats! Where does your talent management go from here?

Pharmaceutical Executive lists need-to-know factors that pharma companies should keep in mind to assess future talent needs, onboard new hires, maintain employee well-being, and more:

#pharma| #hr| #talentmanagement

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs